Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS)

Evidence-based tobacco dependence treatment consists of behavioral counseling and pharmacotherapy. Nicotine patch is an FDA-approved cessation aid. The optimal duration of counseling and pharmacotherapy for patients undergoing low-dose CT (LDCT) lung screening is not clear. In addition, helping smokers to address other social and psychological barriers might help them succeed in quitting smoking. This randomized controlled trial will test, in a factorial design, two options for delivering each of 3 interventions to help current smokers stop smoking in the context of having routine CT lung cancer screening. Patients will receive 4 or 8 weeks of behavioral counseling (with their choice of video conferencing or regular telephone calls), 2 or 8 weeks of nicotine patch, and will receive referral (vs. no referral) to an online resource to connect smokers to community-based social service resources. Outcome measures for smoking cessation will be assessed by a survey administered by phone at 3,and 6 months.

Inclusion criteria

• Scheduled to undergo LDCT-LCS at a participating Mass General Brigham Health Care System LCS site
• Speak English or Spanish.
• Current smokers: smoked a cigarette, even a puff, in the last 30 days.
• Medicare coverage requirement (age 50-80 years, 20+ pack/years).
• Residing within the USA.

Exclusion criteria

• Undergoing lung CT as part of a diagnostic or abnormal follow-up evaluation.
• Unable to give informed consent due to psychiatric or cognitive impairment as determined in consultation with study PI or treating clinician.
• No access to a telephone or cannot communicate by telephone.